Latest Articles
Xella Health Launches with $4.7M to Scale AI-Powered Precision Testing for Women’s Health - HIT Consultant
Xella Health Launches with $4.7M to Scale AI-Powered Precision Testing for Women’s Health HIT Consultant
Published: June 24, 2026, 10:59 p.m.
4 chilling details about the Taylor Parker case missing from “Maternal Instinct” - Yahoo
4 chilling details about the Taylor Parker case missing from “Maternal Instinct” Yahoo
Published: June 24, 2026, 10:31 p.m.
Eli Lilly dives into hair loss treatments with investment in AI startup Absci - statnews.com
Eli Lilly dives into hair loss treatments with investment in AI startup Absci statnews.com
Published: June 24, 2026, 8:05 p.m.
ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise - TradingView
ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise TradingView
Published: June 24, 2026, 7:55 p.m.
Hair Relaxer Lawsuit Settlement | June 2026 Litigation Update - Lawsuit Information Center
Hair Relaxer Lawsuit Settlement | June 2026 Litigation Update Lawsuit Information Center
Published: June 24, 2026, 5:50 p.m.
Absci Raises $100 Million In Equity To Fund AI-Designed Hair Loss And Endometriosis Program - Benzinga
Absci Raises $100 Million In Equity To Fund AI-Designed Hair Loss And Endometriosis Program Benzinga
Published: June 24, 2026, 1:09 p.m.
Absci stock surges 24% on positive Phase 1 hair loss drug data - Investing.com South Africa
Absci stock surges 24% on positive Phase 1 hair loss drug data Investing.com South Africa
Published: June 24, 2026, 11:14 a.m.
Absci stock surges 24% on positive Phase 1 hair loss drug data By Investing.com - Investing.com India
Absci stock surges 24% on positive Phase 1 hair loss drug data By Investing.com Investing.com India
Published: June 24, 2026, 11:13 a.m.
Absci Reports Positive Phase 1 Results for ABS-201, a First-in-Class PRLR Antibody for Hair Regrowth and Endometriosis – Minichart - Minichart
Absci Reports Positive Phase 1 Results for ABS-201, a First-in-Class PRLR Antibody for Hair Regrowth and Endometriosis – Minichart Minichart
Published: June 24, 2026, 10:45 a.m.
Absci Raises $100 Million in Underwritten Offering to Advance ABS-201 Across Androgenetic Alopecia and Endometriosis - Quiver Quantitative
Absci Raises $100 Million in Underwritten Offering to Advance ABS-201 Across Androgenetic Alopecia and Endometriosis Quiver Quantitative
Published: June 24, 2026, 10:41 a.m.
Link copied to clipboard!